94 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
to, statements regarding Vir’s strategy and plans; whether Drs. Bischofberger and Farid are elected to the Board by the Company’s stockholders at the 2024
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
. Forward-looking statements contained in this press release include, but are not limited to, statements regarding Vir’s strategy and plans; Vir’s
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
in connection with the reprioritization, the anticipated timing of such cost impacts and the Company’s strategy and plans. Many factors may cause differences
S-3ASR
ywwfs1p0ehr
3 Nov 23
Automatic shelf registration
4:33pm
8-K
EX-99.1
6ouy 07ph9sxvzj3b
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
mmmij9n nomq4
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
f5mipo1
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
a114bm
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
xoio9wp tz9w
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
EX-99.1
cqzcs58n4f1j9as
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
tkf vycr4kluqpougr3o
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm